#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Epidemiology, Microbiology, Immunology / 2024 - 4

Recurrent meningococcal infections as a sign of inborn error immunity

Czech version

Authors: L. Molnár 1;  Peter Bánovčin 1;  Z. Prohászka 2;  O. Petrovičová 1;  A. Markocsy 1;  M. Jeseňák 1,3,4
Authors‘ workplace: Klinika detí a dorastu, Univerzita Komenského v Bratislave, Jesseniova lekárska fakulta v Martine, Univerzitná nemocnica Martin, Martin, Slovensko 1;  Department of Medicine and Hematology – Research Laboratory, Semmelweis University, Budapes, Hungary 2;  Klinika pneumológie a ftizeológie, Univerzita Komenského v Bratislave, Jesseniova lekárska fakulta v Martine, Univerzitná nemocnica Martin, Martin, Slovensko 3;  Ústav klinickej imunológie a lekárskej genetiky, Univerzita Komenského v Bratislave, Jesseniova lekárska fakulta v Martine, Univerzitna nemocnica Martin, Martin, Slovensko 4
Published in: Epidemiol. Mikrobiol. Imunol. 73, 2024, č. 4, s. 165-172
Category: Original Papers
doi: https://doi.org/10.61568/emi/11-6390/20241024/138871

Overview

Invasive meningococcal diseases (IMD) caused by Neisseria meningitidis are generally rare. They affect mostly selected age categories and risk groups of patients (in terms of age, comorbidities, or applied therapy), and the immune system and its defects may play an important modifying role. Meningococcal infections could be the first and only clinical sign of unrecognised immunodeficiency. IMD are a typical clinical presentation of inborn errors of immunity with low concentrations or dysfunction of the terminal components of complement cascade. Meningitis is present in approximately 40% of the patients with terminal complement components deficiencies and in 6% of the patients with properdin deficiency. Despite evident advances in the understanding of the pathogenesis of meningococcal infections and the mechanisms of immune defence against this pathogen, patients with defects in the alternative or terminal complement pathway are highly predisposed to invasive and recurrent meningococcal infections, usually with a mild course. Therefore, it is recommended that each patient with IMD, especially recurrent, should undergo an immunological examination to rule out complement deficiencies.

Keywords:

complement system – invasive meningococcal diseases – Neisseria meningitides – complement immunodeficiencies – immunological examination

Sources
  1. Arnold L, Borrow R, Riley K, et al. Management of meningococcal disease risk in patients with paroxysmal nocturnal hemoglobinuria (PNH) on complement inhibitors: 18 years’ experience from the UK National PNH Service in Leeds. Blood, 2020;136 (Suppl. 1):5.
  2. Azzari C, Canessa C, Lippi F, et al. Distribution of invasive meningococcal B disease in Italian pediatric population: implications for vaccination timing. Vaccine, 2014;32:1187–1191.
  3. Benamu E, Montoya JG. Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis. Curr Opin Infect Dis, 2016;29(4):319–329.
  4. Bouts A, Monnens L, Davin JC, et al. Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy. Pediatr Nephrol, 2011;26:1919–1920.
  5. Brodszki N, Frazer-Abel A, Grumach AS, et al. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) complement guideline: deficiencies, diagnosis and management. J Clin Immunol, 2020;40: 576–591.
  6. Brodszki N, Skattum L, Bai X, et al. Immune responses following meningococcal serogroup A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies. Vaccine, 2015;33(15):1939–1945.
  7. Caugant DA, Hoiby EA, Magnus P, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol, 1994;32(2):323–330.
  8. Chang Q, Tzeng YL, Stephens DS. Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol, 2012;4:237–245.
  9. Chovancová Z, Hakl R, Litzman J. Komplementový systém I: vrozené poruchy komplementové kaskády vyjma hereditárního angioedému. Čes­slov Pediatr, 2021;76(4):211–217.
  10. Conigliaro P, Triggianese P, Ballanti E, et al. Complement, infection, and autoimmunity. Curr Opin Rheumatol. 2019;31(5):532– 541.
  11. Dubey H, Oster P, Sohail Fazeli M, et al. Risk factors for contracting invasive meningococcal disease and related mortality: a systematic literature review and meta-analysis. Int J Infect Dis, 2022;119:1–9.
  12. Dwilow R, Fanella S. Invasive meningococcal disease in the 21st century – an update for the clinician. Curr Neurol Neurosci Rep, 2015;15(3):2.
  13. Erlich KS, Congeni BL. Importance of circulating antibodies in protection against meningococcal disease. Hum Vaccin Immu­ nother, 2012;8(8):1029–1035.
  14. Feitz WJC, van de Kar NCAJ, Orth-Holler D, et al. The genetics of atypical hemolytic uremic syndrome. Med Genet, 2018;30(4):400–409.
  15. Fijen CAP, Kuijper EJ, Drogari-Apiranthitou M, et al. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol, 1998;114(3):362–369.
  16. Girmenia C, Barcellini W, Bianchi P, et al. Management of infection in PNH patients treated with eculizumab or other complement inhibitors: unmet clinical needs. Blood Rev, 2023;58:101013.
  17. Grumach AS, Kirschfink M. Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Mol Immunol, 2014;61:110–117.
  18. Jonsson G, Truedsson L, Sturfelt G, et al. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Baltimore), 2005;84(1):23–34.
  19. Ladhani SN, Campbell H, Lucidarme J, et al. Invasive meningococcal disease in patients with complement deficiencies: a case series (2008–2017). BMC Infect Dis, 2019;19(1):522.
  20. Lewis LA, Ram S. Meningococcal disease and the complement system. Virulence, 2014;5(1):98–126.
  21. Mannion BA, Weiss J, Elsbach P. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli. J Clin Invest, 1990;86:631–641.
  22. Marshall GS, Ghaswalla PK, Bengtson LGS, et al. Low meningococcal vaccination rates among patients with newly diagnosed complement component deficiencies in the United States. Clin Infect Dis, 2022;75(1):155–158.
  23. Martinon-Torres F, Bernatowska E, Shcherbina A, et al. Meningococcal B vaccine immunogenicity in children with defects in complement and splenic function. Pediatrics, 2018;142(3):e20174250.
  24. McNamara LA, Topaz N, Hariri S, et al. High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR, 2017;66(27):734–737.
  25. Morgan BP, Orren A. Vaccination against meningococcus in complement-deficient individuals. Clin Exp Immunol, 1998;114(3):327–329.
  26. Mulling N, Rohn H, Vogel U, et al. Low efficacy of vaccination against serogroup B meningococci in patients with atypical hemolytic uremic syndrome. Biosci Rep, 2020;40:BSR20200177.
  27. NICE Guideline: Evidence review for risk factors associated with meningococcal disease. London: National Institute for Health and Care Excellence; 2024. ISBN-13: 978-1-4731-5754-5.
  28. Pizza M, Rappuoli R. Neisseria meningitidis: pathogenesis and immunity. Curr Opin Microbiol, 2015;23:68–72.
  1. Platonov AE, Beloborodov VB, Vershinina IV. Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.R. Medicine (Baltimore),1993; 72(6):374–392.
  2. Pollard AJ, Frasch C. Development of natural immunity to Neis­ seria meningitidis. Vaccine, 2001;19(11–12):1327–1346.
  3. Ram S, Lewis LA, Rice PA. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev, 2010;23(4):740–780.
  4. Rosain J, Hong E, Fieschi C, et al. Strains responsible for invasive meningococcal disease in patients with terminal complement pathway deficiencies. J Infect Dis, 2017;215(8):1331–1338. 
  1. Ross SC, Rosenthal PJ, Berberich HM, et al. Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals. J Infect Dis, 1987;155:1266–1275
  2. Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol, 2012;799:1–20.
  3. Skattum L, van Deuren M, van der Poll T, et al. Complement deficiency states and associated infections. Mol Immunol. 2011;48(14):1643–1655.
  4. Šrotová A, Litzman J, Rumlarová Š, et al. Recidivující meningitidy a vrozený deficit komplementového systému. Epidemiol Mikro­ biol Imunol, 2016;65(4):238–242.
  5. Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity, 2007;40(8):560–566.
  6. Villena R, Safadi MAP, Valenyuela MT, et al. Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines. Hum Vac­ cin Immunother, 2018;14(5):1042–1057.
  7. Weil-Olivier C, Taha MK, Leng S, et al. Invasive meningococcal disease in older adults: current perspectives and call for action. Eur Geriatr Med, 2024; doi: 10.1007/s41999-024-00969-0.

Do redakce došlo dne 4. 6. 2023.

Adresa pro korespondenci:
prof. MUDr. Miloš Jeseňák, PhD., MBA, Dott.Ric., MHA
Klinika detí a dorastu UK JLF a UNM
Ústav klinickej imunológie a lekárskej genetiky, JLF UK a UNM
Kollárova 2 036 59 Martin Slovenská republika
e­mail: milos.jesenak@uniba.sk

Labels
Hygiene and epidemiology Medical virology Clinical microbiology
Comparison of procalcitonin levels with blood culture results and foci of infection in septic patients
Kolařík L., Horáková D., Vlčková J., Matoušková I.: Epidemiological situation of Hodgkin’s lymphoma with predictive modeling of global incidence and mortality in 2040
Active surveillance of hospital-acquired infections in Pediatric Intensive Care Unit: a single center study
Accidental detection of malaria by the haematology analyser in a patient at the Adult Emergency Department of the Motol University Hospital
Index
Article was published in

Epidemiology, Microbiology, Immunology

Issue 4
2024 Issue 4
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#